CN116297727A - 一种甲胎蛋白和异常凝血酶原电致发光传感器的制备及其应用 - Google Patents
一种甲胎蛋白和异常凝血酶原电致发光传感器的制备及其应用 Download PDFInfo
- Publication number
- CN116297727A CN116297727A CN202211108629.9A CN202211108629A CN116297727A CN 116297727 A CN116297727 A CN 116297727A CN 202211108629 A CN202211108629 A CN 202211108629A CN 116297727 A CN116297727 A CN 116297727A
- Authority
- CN
- China
- Prior art keywords
- solution
- bispecific antibody
- abnormal prothrombin
- alpha fetoprotein
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000013529 alpha-Fetoproteins Human genes 0.000 title claims abstract description 70
- 108010026331 alpha-Fetoproteins Proteins 0.000 title claims abstract description 70
- 102100027378 Prothrombin Human genes 0.000 title claims abstract description 57
- 108010094028 Prothrombin Proteins 0.000 title claims abstract description 57
- 230000002159 abnormal effect Effects 0.000 title claims abstract description 57
- 229940039716 prothrombin Drugs 0.000 title claims abstract description 57
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 238000001514 detection method Methods 0.000 claims abstract description 17
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims abstract description 14
- 201000007270 liver cancer Diseases 0.000 claims abstract description 11
- 208000014018 liver neoplasm Diseases 0.000 claims abstract description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229910021389 graphene Inorganic materials 0.000 claims abstract description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000002114 nanocomposite Substances 0.000 claims abstract description 7
- 239000002105 nanoparticle Substances 0.000 claims abstract description 7
- 229910052697 platinum Inorganic materials 0.000 claims abstract description 7
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 15
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 239000000427 antigen Substances 0.000 claims description 9
- 102000036639 antigens Human genes 0.000 claims description 9
- 108091007433 antigens Proteins 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 239000007853 buffer solution Substances 0.000 claims description 9
- 238000003745 diagnosis Methods 0.000 claims description 9
- 239000002244 precipitate Substances 0.000 claims description 9
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 9
- 239000012498 ultrapure water Substances 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 8
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- 230000003287 optical effect Effects 0.000 claims description 6
- 238000004393 prognosis Methods 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 6
- 239000012086 standard solution Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000011156 evaluation Methods 0.000 claims description 5
- 238000012544 monitoring process Methods 0.000 claims description 5
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 3
- 229940098773 bovine serum albumin Drugs 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 238000002484 cyclic voltammetry Methods 0.000 claims description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052737 gold Inorganic materials 0.000 claims description 3
- 239000010931 gold Substances 0.000 claims description 3
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229910052707 ruthenium Inorganic materials 0.000 claims description 3
- 239000012488 sample solution Substances 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000009210 therapy by ultrasound Methods 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 4
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 238000000375 direct analysis in real time Methods 0.000 description 2
- 238000012063 dual-affinity re-targeting Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010837 poor prognosis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940019333 vitamin k antagonists Drugs 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/27—Association of two or more measuring systems or cells, each measuring a different parameter, where the measurement results may be either used independently, the systems or cells being physically associated, or combined to produce a value for a further parameter
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Electrochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Plasma & Fusion (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211108629.9A CN116297727B (zh) | 2022-09-13 | 2022-09-13 | 一种甲胎蛋白和异常凝血酶原电致发光传感器的制备及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211108629.9A CN116297727B (zh) | 2022-09-13 | 2022-09-13 | 一种甲胎蛋白和异常凝血酶原电致发光传感器的制备及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116297727A true CN116297727A (zh) | 2023-06-23 |
CN116297727B CN116297727B (zh) | 2024-01-23 |
Family
ID=86801946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211108629.9A Active CN116297727B (zh) | 2022-09-13 | 2022-09-13 | 一种甲胎蛋白和异常凝血酶原电致发光传感器的制备及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116297727B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070292441A1 (en) * | 2004-06-10 | 2007-12-20 | Glover Nicholas R | Tumor Specific Antibody |
CN103245656A (zh) * | 2013-04-25 | 2013-08-14 | 济南大学 | 甲胎蛋白和癌胚抗原电致化学发光传感器的制备及应用 |
KR20180041467A (ko) * | 2016-10-14 | 2018-04-24 | 에스케이텔레콤 주식회사 | 코어-푸코실화 알파-페토프로테인에 특이적으로 결합하는 항체를 이용한 면역 분석법 |
CN109580951A (zh) * | 2018-12-17 | 2019-04-05 | 宁波美丽人生医药生物科技发展有限公司 | 多抗体联合检测早期肝癌标志物的试剂盒及其使用方法 |
CN114414802A (zh) * | 2021-09-23 | 2022-04-29 | 湖南莱拓福生物科技有限公司 | 一种基于肝癌四项联合检测的早期诊断试剂盒及应用 |
-
2022
- 2022-09-13 CN CN202211108629.9A patent/CN116297727B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070292441A1 (en) * | 2004-06-10 | 2007-12-20 | Glover Nicholas R | Tumor Specific Antibody |
CN103245656A (zh) * | 2013-04-25 | 2013-08-14 | 济南大学 | 甲胎蛋白和癌胚抗原电致化学发光传感器的制备及应用 |
KR20180041467A (ko) * | 2016-10-14 | 2018-04-24 | 에스케이텔레콤 주식회사 | 코어-푸코실화 알파-페토프로테인에 특이적으로 결합하는 항체를 이용한 면역 분석법 |
CN109580951A (zh) * | 2018-12-17 | 2019-04-05 | 宁波美丽人生医药生物科技发展有限公司 | 多抗体联合检测早期肝癌标志物的试剂盒及其使用方法 |
CN114414802A (zh) * | 2021-09-23 | 2022-04-29 | 湖南莱拓福生物科技有限公司 | 一种基于肝癌四项联合检测的早期诊断试剂盒及应用 |
Non-Patent Citations (1)
Title |
---|
HAIXIA LIU 等: "THE VALUE OF ALPHA FETOPROTEIN COMBINED WITH ABNORMAL PROTHROMBIN IN THE DIAGNOSIS OF PRIMARY LIVER CANCER", ACTA MEDICA MEDITERRANEA, vol. 37, pages 111 - 114 * |
Also Published As
Publication number | Publication date |
---|---|
CN116297727B (zh) | 2024-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017107974A1 (zh) | 血清psmd4蛋白的检测试剂盒及其检测方法与应用 | |
EP3242133B1 (en) | Composition and system for separating and detecting alpha-fetoprotein variant and use thereof | |
CN110221084B (zh) | 一种快速检测he4和ca125的纳米硒试剂盒 | |
CN102967706B (zh) | 检测肿瘤标志物流动注射化学发光免疫传感器的制备及应用 | |
CN105301241B (zh) | 用于检测肿瘤标志物的夹心式电化学发光免疫传感器的制备方法及其应用 | |
CN107543932A (zh) | 一种降钙素的磁微粒化学发光检测试剂盒及制备方法 | |
CN103364558A (zh) | 一种人肿瘤标志物癌胚抗原(cea)的磁微粒化学发光免疫分析试剂盒及其检测方法 | |
CN107677806B (zh) | 基于磁富集的荧光定量高灵敏可视化联检免疫层析试纸条的制备和检测方法 | |
CN103344634A (zh) | 一种人甲胎蛋白(afp)的磁微粒化学发光免疫分析试剂盒及其检测方法 | |
CN108351358A (zh) | 肝癌测试方法 | |
CN103439511B (zh) | 一种检测肺癌的液相芯片试剂盒 | |
CN109669044A (zh) | 基于双色量子点联合检测saa和crp的荧光免疫吸附检测试剂盒及其制备方法 | |
CN106950374A (zh) | Glypican‑1蛋白在胰腺癌诊断中的应用、阳性外泌体浓度的检测方法及其用途 | |
CN109187971A (zh) | 神经元特异性烯醇化酶化学发光免疫检测试剂盒及其制备方法 | |
CN109187979A (zh) | 蛋白芯片、蛋白质芯片诊断试剂盒制备及使用方法 | |
JP5104622B2 (ja) | 磁性粒子を用いた測定対象物質の濃度測定法 | |
CN116297727B (zh) | 一种甲胎蛋白和异常凝血酶原电致发光传感器的制备及其应用 | |
CN1987468B (zh) | 血管内皮生长因子时间分辨荧光免疫分析方法及试剂盒 | |
CN105259348B (zh) | 一种分泌型Sema4C蛋白及其应用 | |
CN109239332A (zh) | 一种辅助检测亚健康人群癌坯抗原的试剂盒 | |
CN107746430B (zh) | 一种gp73 c端抗原的制备及其应用 | |
CN110261611B (zh) | Znf709蛋白作为胃癌血清生物标志物的应用及其试剂盒 | |
CN110261618B (zh) | Sprr4蛋白作为胃癌血清生物标志物的应用及其试剂盒 | |
WO2011158769A1 (ja) | 非アルコール性脂肪肝炎検出および/または鑑別用マーカー、非アルコール性脂肪肝炎を検出および/または鑑別する方法およびそれらに用いるキット | |
CN108362884B (zh) | 一种肿瘤危险度和治疗效果评估的血清及组织分子指标 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240418 Address after: Room 507, Apartment Building, Dingwang Packaging Park, Private Economic Industrial Park, Yuhuangmiao Town, Shanghe County, Jinan City, Shandong Province, 251600 Patentee after: Shandong Pinfeng Medical Technology Co.,Ltd. Country or region after: China Address before: 250012 No. 107 west Wenhua Road, Lixia District, Shandong, Ji'nan Patentee before: QILU HOSPITAL OF SHANDONG University Country or region before: China Patentee before: Shandong Zhonghong special inspection Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right |